In the basal ganglia structure of the midbrain, substantia nigra plays an important role, especially in the regulation of reward and movement.This structure is named after its dopamine neurons containing high concentrations of neuromelanin, and appears to be darker than the surrounding area.However, in contrast to this unique structure, dopamine neurons in the substantia nigra are extremely fragile, especially under the influence of Parkinson's disease, and their death has become a well-thought-out issue.
The characteristic of Parkinson's disease is that the gradual death of dopamine neurons in the substantia nigra (SNpc), which is accompanied by the emergence of symptoms such as movement disorders.
The structure of substantia nigra can be divided into two parts: compact part (SNpc) and mesh part (SNpr).The compact part mainly projects dopamine to the basal ganglion circuit, while the reticle part is responsible for delivering signals from the basal ganglion to other areas of the brain.The complexity of this structure reveals its importance in sports and reward mechanisms and its interconnected nature.
It is currently known that dopamine neurons of substantia nigra are highly special in structure and function.Although the process of death in neurons cannot be fully explained, studies have shown that the loss of dopamine signaling leads to many neuropsychiatric disorders.Especially in Parkinson's disease, the dynamic changes in this process have attracted deep attention from scientists.
Scientists speculate that compact dopamine neurons make them more susceptible to oxidative stress due to their less calcium-binding protein, which may explain their vulnerability in Parkinson's patients.
Neural transmission pathways involved in substantia nigra function vary, including direct and indirect pathways, which interact closely in motor control and behavioral responses.Even though some studies have pointed out that there is a close path structure between the SNpr and the outer spherical nucleus, how such anatomical linkage corresponds to actual behavioral responses is still a question to be solved.
In the clinical sense, the health of substantia nigra means the patient's motor ability and behavioral performance, which directly affects their quality of life.As Parkinson's disease progresses, patients often show a variety of different symptoms, including slow movement, stiffness, and depression, so it is particularly important to interpret the mechanism behind this phenomenon.
Dopamine neurons in Parkinson's disease patients become functionally unbalanced and the brain's operating mode is significantly disturbed, which leads to difficulties in the patient's motor control.
While there are currently a variety of treatments to combat the effects of Parkinson's disease, including the use of dopamine prodrugs to supplement the missing dopamine, these treatments can only relieve symptoms in the short term and cannot reverse the neuron's death process.Some researchers have also focused on gene therapy or stem cell research, hoping to find more effective and lasting solutions.
The specific causes of death of dopamine neurons in substantia nigra has been continuously studied, and with in-depth exploration of its mechanism, we may be able to find more prospective treatments.However, this process raises a fundamental question: Why are these dopamine neurons more vulnerable than others and, in the face of various challenges, particularly vulnerable to damage?